Cyclacel Pharmaceuticals shares declined 13.54 percent on volume of 2.58 million shares traded to close at $3.00 a share. The company announced the pricing of an underwritten offering of 6,666,667 shares of its common stock at $3.00 per share.
Going forward ... (see research report)
Copyright ® 2014. The Bedford Report. All Rights Reserved.